P&F Studies

2016
Pilot Awardee	Center	Pilot Study
Rotonya M Carr MD	University of Pennsylvania	Mechanisms of Lipid Dysregulation and Insulin Resistance in Alcoholic Liver Disease
Jennifer Cochran PhD	Stanford University	Engineering agonists of the glucagon-like peptide-1 receptor with novel pharmacological properties for the study and therapeutic control of diabetes
Brian DeBosch MD PhD	Washington University in St Louis	Mechanisms of trehalose action in modulating hepatic and extrahepatic metabolism
Carol F Elias PhD	University of Michigan	Cellular and molecular basis of diabetes-induced placental dysfunction
F Martin Fisher PhD	Boston Area	Defining the Role of the Thermogenic Adipocyte in Mediating the Pharmacologic Actions of Fgf21
Jonathan Flak PhD	University of Michigan	Uncovering the neurocircuitry that drive counterregulation downstream from the VMN
Amy Miskimon Goss PhD RD	University of Alabama at Birmingham	Carbohydrate restricted diet to reverse fatty liver in adolescents with obesity
Justin M Gregory MD	Vanderbilt University	Peripheral Insulin Delivery's Contribution to Insulin Resistance in Type 1 Diabetes
Eric Gross MD	Stanford University	Generation of endothelial cells resistant to hyperglycemia-induced endothelial cell dysfunction
Carrie A Grueter PhD	Vanderbilt University	DGAT1 as a central regulator of diet-induced obesity
Subhadra Gunawardana PhD	Washington University in St Louis	Insulin-independent reversal of diabetes with BAT transplants: role of IGF-1
Lydia-Ann Harris PhD	Washington University in St Louis	A role for FGF21 in the weight loss-independent metabolic effects of Roux-en-Y gastric bypass
Jorge Henao-Mejia MD PhD	University of Pennsylvania	Anti-inflammatory IncRNA therapy
Elvira Isganaitis MD MPH	Boston Area	Novel Mediators of Excessive Fetal Growth in Type 1 Diabetes Pregnancy